Aptamer Group plc (APTA) ORD GBP0.0001
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Aptamer applies for patent over binder sequences developed with Unilever
8 April 2024 11:25
(Sharecast News) - Aptamer Group announced the submission of a patent application safeguarding newly-crafted Optimer binder sequences on Monday.
-
Aptamer reports decent technical, commercial progress
15 December 2023 11:06
(Sharecast News) - Aptamer Group reported solid progress on both the technical and commercial fronts on Friday as it held its annual general meeting.
-
Aptamer inks £0.55m agreement with biotech firm
14 December 2023 16:43
(Sharecast News) - Aptamer Group announced a significant agreement with a biotechnology company on Thursday, focussed on genetic medicines.
-
Aptamer secures two contracts with big pharma firm
17 August 2023 15:51
(Sharecast News) - Life sciences company Aptamer Group has secured two new contracts with one of the world's top five pharmaceutical companies, it announced on Thursday, with an estimated worth of up to...
-
Aptamer announces four significant new contracts
7 July 2023 13:40
(Sharecast News) - Life sciences company Aptamer Group announced a significant update on recent contract wins on Friday, totalling up to £0.51m over the next six months.
-
Aptamer warns on profits amid slow pipeline conversion
5 May 2023 15:48
(Sharecast News) - Life sciences company Aptamer Group said in a trading update on Friday that revenue in the 10 months ended 30 April totalled around £1.4m.
-
Aptamer warns on FY revenues
3 January 2023 08:36
(Sharecast News) - Biotech company Aptamer Group warned on Tuesday that while full-year revenues may fall short of market expectations, they were still likely to come in "materially ahead" of the...
Company announcements Announcements
-
Holding(s) in Company
25 April 2024 15:45
Aptamer Group
-
Holding(s) in Company
24 April 2024 08:45
Aptamer Group
-
Holding(s) in Company - REPLACEMENT
23 April 2024 14:03
Aptamer Group
-
Holding(s) in Company
22 April 2024 16:37
Aptamer Group
-
Top Pharma Company evaluates Optimer for medicine
22 April 2024 07:00
Aptamer Group
-
TR-1: Notification of major holdings
18 April 2024 10:06
Aptamer Group
-
Aptamer and Kairos Biotech partner for Optimer+
18 April 2024 07:00
Aptamer Group
-
Patent submission for Optimer® binders
8 April 2024 07:00
Aptamer Group
-
Holding(s) in Company
28 March 2024 14:07
Aptamer Group
-
Interim Results
28 March 2024 07:00
Aptamer Group
-
Notice of Interim Results & Investor Presentation
22 March 2024 07:00
Aptamer Group
-
Aptamer Progresses Partnership with Unilever
11 March 2024 07:00
Aptamer Group
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.